{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:21:57Z","timestamp":1779110517675,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.urolonc.2012.03.021","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T00:16:10Z","timestamp":1335226570000},"page":"1820-1825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Paraneoplastic symptoms: Cachexia, polycythemia, and hypercalcemia are, respectively, related to vascular endothelial growth factor (VEGF) expression in renal clear cell carcinoma"],"prefix":"10.1016","volume":"31","author":[{"given":"Guan-xiong","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-chen","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning-hong","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zu-jun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-wei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-wen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-xin","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2012.03.021_bib1","first-page":"23","article-title":"Cancer statistics","volume":"52","author":"Jemal","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2012.03.021_bib2","series-title":"Pathology and genetics of tumours of the urinary system and male genital organs","author":"Eble","year":"2004"},{"key":"10.1016\/j.urolonc.2012.03.021_bib3","series-title":"Campbell's Urology","first-page":"p. 2672","article-title":"Renal tumours","author":"Novick","year":"2002"},{"key":"10.1016\/j.urolonc.2012.03.021_bib4","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJM199609193351207","article-title":"Renal-cell carcinoma","volume":"335","author":"Motzer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2012.03.021_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0022-5347(17)67032-0","article-title":"Renal cell carcinoma: Natural history and chemotherapeutic experience","volume":"114","author":"Lokich","year":"1975","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.03.021_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000224860","article-title":"Paraneoplastic syndromes in patients with urological malignancies","volume":"83","author":"Sacco","year":"2009","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2012.03.021_bib7","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1097\/01.ju.0000092764.81308.6a","article-title":"Paraneoplastic signs and symptoms of renal cell carcinoma: Implications for prognosis","volume":"170","author":"Kim","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.03.021_bib8","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1097\/01.ASN.0000092803.69761.41","article-title":"The von Hippel-Lindau gene, kidney cancer, and oxygen sensing","volume":"14","author":"Kaelin","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.urolonc.2012.03.021_bib9","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.eururo.2010.06.032","article-title":"EAU guidelines on renal cell carcinoma: The 2010 update","volume":"58","author":"Ljungberg","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2012.03.021_bib10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/039463200802100225","article-title":"Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up","volume":"21","author":"Minardi","year":"2008","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.urolonc.2012.03.021_bib11","series-title":"International Union against Cancer (UICC). TNM classification of malignant tumours, 6th ed","author":"Sobin","year":"2002"},{"key":"10.1016\/j.urolonc.2012.03.021_bib12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00000478-198210000-00007","article-title":"Prognostic significance of morphologic parameters in renal cell carcinoma","volume":"6","author":"Fuhrman","year":"1982","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2012.03.021_bib13","doi-asserted-by":"crossref","unstructured":"Ding GX,Song NH, Feng CC, et al. Is there an association between advanced stage of renal cell carcinoma and paraneoplastic syndrome? Med Princ Pract 2012 Jan 6. [Epub ahead of print].","DOI":"10.1159\/000334873"},{"key":"10.1016\/j.urolonc.2012.03.021_bib14","first-page":"163","article-title":"Paraneoplastic syndromes in urologic malignancy: The many faces of renal cell carcinoma","volume":"4","author":"Palapattu","year":"2002","journal-title":"Rev Urol"},{"key":"10.1016\/j.urolonc.2012.03.021_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00000421-199906000-00003","article-title":"Renal cell carcinoma: A paradigm of lanthanic disease","volume":"22","author":"Papac","year":"1999","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.urolonc.2012.03.021_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01741856","article-title":"Interleukin-6 and renal cell cancer: Production, regulation, and growth effects","volume":"35","author":"Koo","year":"1992","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.urolonc.2012.03.021_bib17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/(SICI)1097-0215(19970729)72:3<424::AID-IJC9>3.0.CO;2-R","article-title":"Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma","volume":"72","author":"Blay","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2012.03.021_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(98)03544-2","article-title":"Renal cancer collaborators. Interferon-\u03b1 and survival in metastatic renal carcinoma: Early results of a randomized controlled trial. Medical Research Council renal cancer collaborators","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2012.03.021_bib19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/JCO.2002.20.1.289","article-title":"Interferon-&;\u03b1 as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma","volume":"20","author":"Motzer","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2012.03.021_bib20","first-page":"CD001425","article-title":"Immunotherapy for advanced renal cell cancer","volume":"1","author":"Coppin","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.urolonc.2012.03.021_bib21","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1200\/JCO.2003.02.122","article-title":"Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer","volume":"21","author":"Yang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2012.03.021_bib22","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1200\/JCO.2005.01.186","article-title":"Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma","volume":"23","author":"Rini","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2012.03.021_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/annonc\/mdi002","article-title":"Renal cell carcinoma: Review of novel single-agent therapeutics and combination regimens","volume":"16","author":"Amato","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urolonc.2012.03.021_bib24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm0603-653","article-title":"Angiogenesis in health and disease","volume":"9","author":"Carmeliet","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.urolonc.2012.03.021_bib25","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.urolonc.2012.03.021_bib26","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1091\/mbc.4.12.1317","article-title":"The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF","volume":"4","author":"Park","year":"1993","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.urolonc.2012.03.021_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa060655","article-title":"Sorafenib in advanced clear-cell renal-cell carcinoma","volume":"356","author":"Escudier","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2012.03.021_bib28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1200\/JCO.2005.02.2574","article-title":"Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma","volume":"24","author":"Motzer","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2012.03.021_bib29","author":"Ljungberg"},{"key":"10.1016\/j.urolonc.2012.03.021_bib30","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1182\/blood.V99.10.3562","article-title":"Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma","volume":"99","author":"Wiesener","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.urolonc.2012.03.021_bib31","first-page":"29l","article-title":"Prognostic significance of erythropoietin expression in human renal cell carcinoma","volume":"100","author":"Mihael","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2012.03.021_bib32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000050980","article-title":"Rapidly relapsing squamous cell carcinoma of the renal pelvis associated with paraneoplastic syndromes of leukocytosis, thrombocytosis and hypercalcemia","volume":"67","author":"Er","year":"2001","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2012.03.021_bib33","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00000658-197111000-00019","article-title":"Concurrence of hypernephroma and hypercalcemia","volume":"174","author":"Warren","year":"1971","journal-title":"Ann Surg"},{"key":"10.1016\/j.urolonc.2012.03.021_bib34","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJM198406283102607","article-title":"The hypercalcemia of cancer","volume":"310","author":"Mundy","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2012.03.021_bib35","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s12032-009-9327-4","article-title":"Recovery of paraneoplastic hypercalcemia by sunitinib treatment for renal cell carcinoma: A case report and review of the literature","volume":"27","author":"Karaca","year":"2010","journal-title":"Med Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143912001299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143912001299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:04:11Z","timestamp":1761041051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143912001299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1078143912001299"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2012.03.021","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paraneoplastic symptoms: Cachexia, polycythemia, and hypercalcemia are, respectively, related to vascular endothelial growth factor (VEGF) expression in renal clear cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2012.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}